日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/24 | 2,013 | 2,163 | 2,010 | 2,160 | +148 | +7.4% | 5,500 |
2020/03/23 | 2,081 | 2,098 | 2,000 | 2,012 | +21 | +1.1% | 6,700 |
2020/03/19 | 2,053 | 2,053 | 1,983 | 1,991 | -12 | -0.6% | 5,500 |
2020/03/18 | 2,050 | 2,055 | 2,000 | 2,003 | -44 | -2.1% | 5,300 |
2020/03/17 | 1,901 | 2,060 | 1,900 | 2,047 | +70 | +3.5% | 10,600 |
2020/03/16 | 1,951 | 2,025 | 1,947 | 1,977 | +105 | +5.6% | 5,800 |
2020/03/13 | 1,766 | 1,948 | 1,766 | 1,872 | -80 | -4.1% | 15,100 |
2020/03/12 | 2,010 | 2,026 | 1,900 | 1,952 | -18 | -0.9% | 10,400 |
2020/03/11 | 2,059 | 2,063 | 1,961 | 1,970 | -71 | -3.5% | 8,100 |
2020/03/10 | 1,950 | 2,055 | 1,832 | 2,041 | -9 | -0.4% | 18,100 |
2020/03/09 | 2,260 | 2,261 | 2,035 | 2,050 | -202 | -9% | 7,200 |
2020/03/06 | 2,301 | 2,301 | 2,252 | 2,252 | -78 | -3.3% | 6,600 |
2020/03/05 | 2,349 | 2,367 | 2,330 | 2,330 | +1 | ±0% | 4,700 |
2020/03/04 | 2,311 | 2,346 | 2,311 | 2,329 | +18 | +0.8% | 4,300 |
2020/03/03 | 2,400 | 2,420 | 2,311 | 2,311 | -61 | -2.6% | 7,200 |
2020/03/02 | 2,303 | 2,423 | 2,295 | 2,372 | +69 | +3% | 4,600 |
2020/02/28 | 2,324 | 2,380 | 2,299 | 2,303 | -156 | -6.3% | 11,800 |
2020/02/27 | 2,531 | 2,544 | 2,453 | 2,459 | -73 | -2.9% | 8,100 |
2020/02/26 | 2,540 | 2,577 | 2,532 | 2,532 | -10 | -0.4% | 7,300 |
2020/02/25 | 2,640 | 2,640 | 2,542 | 2,542 | -129 | -4.8% | 12,500 |
2020/02/21 | 2,620 | 2,671 | 2,616 | 2,671 | +55 | +2.1% | 6,200 |
2020/02/20 | 2,700 | 2,700 | 2,583 | 2,616 | -56 | -2.1% | 10,800 |
2020/02/19 | 2,526 | 2,896 | 2,526 | 2,672 | +148 | +5.9% | 35,300 |
2020/02/18 | 2,596 | 2,601 | 2,524 | 2,524 | -84 | -3.2% | 7,000 |
2020/02/17 | 2,648 | 2,673 | 2,591 | 2,608 | -42 | -1.6% | 14,900 |
2020/02/14 | 2,661 | 2,669 | 2,650 | 2,650 | -11 | -0.4% | 2,700 |
2020/02/13 | 2,646 | 2,674 | 2,643 | 2,661 | +3 | +0.1% | 2,900 |
2020/02/12 | 2,644 | 2,660 | 2,635 | 2,658 | +15 | +0.6% | 1,200 |
2020/02/10 | 2,645 | 2,654 | 2,635 | 2,643 | +3 | +0.1% | 4,900 |
2020/02/07 | 2,638 | 2,654 | 2,635 | 2,640 | -5 | -0.2% | 2,600 |
2020/02/06 | 2,606 | 2,660 | 2,606 | 2,645 | +34 | +1.3% | 5,700 |
2020/02/05 | 2,637 | 2,664 | 2,611 | 2,611 | -14 | -0.5% | 7,900 |
2020/02/04 | 2,680 | 2,681 | 2,600 | 2,625 | -42 | -1.6% | 11,300 |
2020/02/03 | 2,799 | 2,799 | 2,592 | 2,667 | -313 | -10.5% | 36,300 |
2020/01/31 | 3,030 | 3,030 | 2,960 | 2,980 | -50 | -1.7% | 1,900 |
2020/01/30 | 3,020 | 3,030 | 2,944 | 3,030 | +10 | +0.3% | 8,000 |
2020/01/29 | 2,995 | 3,050 | 2,990 | 3,020 | +28 | +0.9% | 2,700 |
2020/01/28 | 2,949 | 2,992 | 2,946 | 2,992 | -7 | -0.2% | 4,300 |
2020/01/27 | 3,070 | 3,070 | 2,999 | 2,999 | -21 | -0.7% | 3,900 |
2020/01/24 | 3,055 | 3,055 | 3,020 | 3,020 | -5 | -0.2% | 3,200 |
2020/01/23 | 3,010 | 3,035 | 3,005 | 3,025 | -10 | -0.3% | 5,600 |
2020/01/22 | 3,010 | 3,040 | 3,010 | 3,035 | +25 | +0.8% | 2,700 |
2020/01/21 | 3,060 | 3,060 | 3,010 | 3,010 | -50 | -1.6% | 3,800 |
2020/01/20 | 3,110 | 3,115 | 3,030 | 3,060 | -40 | -1.3% | 8,300 |
2020/01/17 | 3,275 | 3,275 | 3,070 | 3,100 | -130 | -4% | 26,000 |
2020/01/16 | 3,150 | 3,300 | 3,115 | 3,230 | +303 | +10.4% | 53,800 |
2020/01/15 | 2,874 | 2,927 | 2,874 | 2,927 | +24 | +0.8% | 3,300 |
2020/01/14 | 2,882 | 2,907 | 2,875 | 2,903 | +12 | +0.4% | 2,700 |
2020/01/10 | 2,900 | 2,924 | 2,890 | 2,891 | -6 | -0.2% | 700 |
2020/01/09 | 2,877 | 2,937 | 2,873 | 2,897 | +24 | +0.8% | 4,300 |
1301~
1350
件表示中 / 3742件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 148,700円 | +7.5% | -77.4% | 3.36% | 35.77倍 | 0.28倍 |
|
後発薬中堅、検査薬事業が第2の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
ノイルイミューン | 17,300円 | -28.6% | - | 0.00% | - | 1.59倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
モダリス | 8,800円 | - | - | 0.00% | - | 1.92倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
DWTI | 13,100円 | -15.1% | - | 0.00% | - | 8.19倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
ペルセウス | 40,500円 | +25.0% | - | 0.00% | - | 4.42倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
市場注目の銘柄
チャート関連のコラム